CH4 Natural Solutions Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026, disclosing financial results and balance sheet data for the SPAC following its April 2026 initial public offering.

Key Highlights

  • Trust Account: Cash held in the Trust Account stood at $223,285,819 as of September 30, 2026, compared to zero at December 31, 2025.
  • Net Income (Q3): The company reported net income of $1,744,109 for the three months ended September 30, 2026, driven by $2,051,985 in interest on cash held in the Trust Account.
  • Nine-Month Net Loss: For the nine months ended September 30, 2026, the company reported a net loss of $4,150,208, with general and administrative expenses of $7,436,027.
  • Shares Outstanding: As of November 13, 2026, there were 22,200,000 Class A ordinary shares and 7,333,334 Class B ordinary shares issued and outstanding.
  • Redeemable Shares: 22,000,000 Class A ordinary shares are subject to possible redemption at $10.15 per share as of September 30, 2026.
  • Total Liabilities: Total liabilities were $15,366,912 at September 30, 2026, including $6,600,000 in deferred underwriting fees and $6,600,000 in advisory fees payable.
  • Accumulated Deficit: The company reported an accumulated deficit of $14,439,562 at September 30, 2026, versus $296,739 at December 31, 2025.

CH4 Natural Solutions Reports First Full Quarter After IPO, Trust Earns $3.3M in Interest

According to the filing, CH4 Natural Solutions Corporation (NYSE:MTNE), a Cayman Islands-incorporated SPAC headquartered at 712 Fifth Avenue, 36th Floor, New York, NY, completed its initial public offering in late April 2026 and held $223,285,819 in its Trust Account as of September 30, 2026. The company disclosed that its prospectus was dated April 30, 2026, and that the underwriter partially exercised its over-allotment option on May 6, 2026, purchasing 2,000,000 additional units on May 8, 2026. Upon expiration of the over-allotment period on June 15, 2026, the underwriter forfeited remaining rights, and the sponsor forfeited 333,333 Class B ordinary shares.

The filing reported that for the three months ended September 30, 2026, general and administrative expenses were $307,876 and interest earned on the Trust Account was $2,051,985, resulting in net income of $1,744,109. For the nine-month period ended September 30, 2026, the company reported a net loss of $4,150,208, with general and administrative expenses of $7,436,027 partially offset by $3,285,819 in trust interest. Basic and diluted net income (loss) per share for all share classes for the three- and nine-month periods was $0.06 and $(0.22), respectively, according to the filing.

The company disclosed total assets of $224,213,922 against total liabilities of $15,366,912, leaving a total shareholders' deficit of $(14,438,809) at September 30, 2026. The filing also noted that in November 2025 the sponsor received a share dividend resulting in 11,500,000 founder shares, and that on April 22, 2026, the sponsor surrendered 3,833,333 founder shares for no consideration, leaving 7,666,667 before the subsequent forfeiture of 333,333. The company identified itself as a shell company, smaller reporting company, and emerging growth company.

What Was Disclosed

CH4 Natural Solutions Corporation filed its quarterly report covering the period ended September 30, 2026, disclosing Trust Account balances, operating losses, share capital changes following its April 2026 IPO, deferred underwriting and advisory fees, and an accumulated deficit of $14,439,562.